Member Info for HallsWorthy

Could apply to see the share register, from memory it's like £35 to get it but not certain. They legally have to give it to you

A cash divi would be good but unlikely, I think a lot of investors would plough it straight back into orph shares at this level, I would for sure. Or use some money for a buyback

One day sooner?

Minor delay?! Brief period?! How can a small admin error lead to a ONE MONTH delisting! This utterly stinks

Interesiting looking one this, looks primed for a big break out, bouncing off lows with decent volume and a tiny market cap. Can someone educate me what the main piece(s) of news being waited on is? What's the main buy case here?

Finally the next presentation is here and Cathal never disappoints in steadying the nerves. Should be a decent couple of days

The start of a better week you'd hope, with Cathal presenting I doubt he wants to go in with nothing to talk about so RNS tomorrow or weds

Very interesting to learn the reasonings, there is always a motive to the deramping and they are never open about their reasons for sitting on boards and bashing shares

alwyas bounces from here about 10%, traders paradise. Might join them this time!

1 a month doesn't mean literally one every 30 days.

Haha you think dim announcement wouldn't move the share price, are you crazy

Is the board not working or something

Yes, I read it, did you? Where in the article does it back up your lie?

"It confirms that the Delta variant characterisation study is on track for completion later this year"
->No it doesn't. Why am I positive about that? 'Cos Dr Catchpole has said so: "... with the trials using the strain set to begin at the end of the year."

You've just contradicted yourself. How could trials start by the end of the year if the characterisation study wasn't completed before then? You do know the difference between the study and a trial ...right?

I think the only/main reason someone gets banned is posting under multiple usernames. Should be able to work out who else stopped posting around the same time ;)

Why did the Bronxville account get banned?

Great money saver

Anyone wondering if Monday is bringing news?

This is a very rapidly expanding company and should be valued like a startup, not a dividend paying company that has been steady for 10 years+. Its a bit ridiclous to use profit instead of revenue for a company that is only just transitioning into the former!

The average revenue multiple for startup valuation is 1x – 5x for startups that are growing very slowly (~10% per year), 6x – 10x for startups that are growing in the lower two digits (30-40% per year), and 10x – 20x for tech startups that are growing in the three digits (300-400% per year).

With revenue forecast at around £50m non covid and potentially double with covid, then everyone can make their own minds up where orph falls in those suggestions.

JimBeann, why are you asking here? Go and ask investor relations yourself